The European Medicines Agency is making it mandatory for drug companies to use a new consistent international standard – the International Organization for Standardization’s individual case safety report (ICSR) format – for reporting individual cases of suspected side-effects in patients as of 30 June 2022.
The use of the ISO ICSR format will become mandatory for all reporting to EudraVigilance, the European database of suspected...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?